NICE Scientific Advice
About usNICE Scientific Advice (SA) provides fee-for-service consultation to pharmaceutical companies. By reviewing early product development plans we can advise companies on whether these will generate relevant evidence for future submissions to NICE. |
2013 Seminar programmeScientific advice: A NICE perspective on pharmaceutical product development Developing a Value Proposition: Devices & Diagnostics Registration opens soon! |
Pharmaceutical products
|
Devices and diagnostics
Contact us to discuss the most appropriate option for your product. |
NICE Scientific Advice was set up in 2009 to offer product-specific scientific advice to pharmaceutical companies about products they have in development that may be referred for a future NICE evaluation.
Based on a briefing book, written questions submitted by the company and a face-to-face meeting, NICE SA provides an advice report. There is a fee for this service.
More recently NICE SA has expanded the range of services we offer to give advice alongside regulators.
Why seek advice?
NICE evaluation programmes require certain types of evidence about the technology being appraised. A company may wish to seek advice from NICE to ensure that their proposed development plans can produce evidence that is relevant for a future NICE evaluation.
When can advice be sought?
Advice can be sought at any time. However, a useful time for requesting scientific advice could be during phase II studies before the planning of phase III studies. The earlier in the development process the less specific the advice can be, and the later in the process the less likely it is that companies will be able to make changes to the design of clinical trials.
This page was last updated: 11 April 2013